Article Details

Ginkgo Bioworks acquires Zymergen for $300M - PharmaLive

Retrieved on: 2022-07-27 10:55:56

Tags for this article:

Click the tags to see associated articles and topics

Ginkgo Bioworks acquires Zymergen for $300M - PharmaLive. View article details on hiswai:

Excerpt

... capabilities for a wide range of biological engineering approaches. ... Ginkgo and Bayer, through Leaps, jointly launched Joyn Bio in 2017.

Article found on: www.pharmalive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up